1.
Bioorg Med Chem Lett
; 17(6): 1722-5, 2007 Mar 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17267215
RESUMO
High-throughput screening of the corporate compound collection led to the discovery of a novel series of N-substituted-5-aryl-oxazolidinones as potent human CCR8 antagonists. The synthesis, structure-activity relationships, and optimization of the series that led to the identification of SB-649701 (1a), are described.